SMARCD2 and leukemia: To assess the relevance of our observations in a physiological context, we transplanted sublethally-irradiated mice with MLL-AF9 cells transduced with shRNAs targeting either Smarca4, Smarcd2, Dpf2, or non-targeting control (shScr) and monitored mice for the onset of leukaemia.